Section 202 – Duties.
Effective 5/4/2022 26-61-202. Duties. (1) The board shall review any available scientific research related to the human use of cannabis, a cannabinoid product, or an expanded cannabinoid product that: (a) was conducted under a study approved by an IRB; (b) was conducted or approved by the federal government; or (c) (i) was conducted in another […]
Section 103 – Institutional review board — Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product.
Effective 3/25/2017 26-61-103. Institutional review board — Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product. (1) A person conducting an approved study may, for the purposes of the study: (a) process a cannabinoid product or an expanded cannabinoid product; (b) possess a cannabinoid product or an expanded cannabinoid product; and (c) […]
Section 201 – Cannabis Research Review Board.
Effective 3/24/2022 26-61-201. Cannabis Research Review Board. (1) There is created the Cannabis Research Review Board within the department. (2) The department shall appoint, in consultation with a professional association based in the state that represents physicians, seven members to the Cannabis Research Review Board as follows: (a) three individuals who are medical research professionals; […]